Fingerprint
Dive into the research topics of 'The bivalent ligand, MMG22, reduces neuropathic pain after nerve injury without the side effects of traditional opioids'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The bivalent ligand, MMG22, reduces neuropathic pain after nerve injury without the side effects of traditional opioids
Rebecca Speltz, Mary M. Lunzer, Sarah S. Shueb, Eyup Akgün, Rachelle Reed, Alex Kalyuzhny, Philip S. Portoghese, Donald A. Simone
Research output: Contribution to journal › Article › peer-review
3
Scopus
citations